If the solubility of a drug is insufficient and suitable salts or co-crystals cannot be produced, you may need to formulate a drug in its amorphous state, since the solubility will be higher than that of the crystalline substance. A way to kinetically stabilize the amorphous state is to form so-called amorphous dispersions, where the active ingredient is molecularly dispersed in a glassy polymer matrix. Key to successfully forming such an amorphous dispersion is to identify the optimal polymer for a particular drug substance. Sortis has developed appropriate methods to quickly identify such polymers so test samples can be produced and assessed for their stability.